₹ 20,322.00
486.00 (2.45%)
N
Neuland Laboratories
₹ 20,322.00
Neuland Laboratories EPS Summary (consolidated)
The latest quarterly EPS of Neuland Laboratories as of Q2 Sep 2026 stands at ₹40.24. This is a 65.04% fall quarter on quarter and 46.69% fall same quarter last year. The forecasted EPS for Q2 Sep 2026 was ₹69.51. It missed the estimate by ₹29.27. For the FY2026 the EPS of Neuland Laboratories stands at ₹283.71. This is a 39.94% growth compared with FY2025.
Neuland Laboratories EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

